Table 3 Association of patient characteristics with improvement of LVEF : univariate and multivariate regression analysis

Variable

OR(95% CI)

P value

OR(95% CI)

P value

Age(year)

0.94(0.88–0.99)

0.024

0.97(0.90–1.04)

0.324

Female n(%)

0.64(0.23–1.84)

0.410

Weight(kg)

1.03(0.99–1.07)

0.138

BMI(kg/m²)

1.08(0.92–1.26)

0.349

AF duration (months)

0.99(0.97–1.01)

0.311

LVEF(%)

0.92(0.82–1.03)

0.133

LVDd(mm)

0.86(0.78–0.95)

0.004

0.85(0.76–0.95)

0.005

LAD(mm)

0.99(0.88–1.10)

0.820

Hypertension(%)

1.00(0.36–2.81)

1.000

Diabetes(%)

0.56(0.11–2.78)

0.475

CHD(%)

0.92(0.29–2.93)

0.883

Previous stroke n(%)

1.49(0.45–4.96)

0.520

NT-pro BNP(pg/ml)

1.00(1.00–1.00)

0.221

Hb(g/L)

1.02(1.00-1.06)

0.105

eGFR(ml/min/1.73m²)

1.04(1.01–1.07)

0.009

1.01(0.98–1.06)

0.395

TC(mmol/L)

1.41(0.75–2.66)

0.284

TG(mmol/L)

0.75(0.24–2.33)

0.617

LDL-C(mmol/L)

0.97(0.90–1.05)

0.470

HDL-C(mmol/L)

8.91(0.69–114.90)

0.094

7.35(0.26-208.54)

0.243

ACEI/ARB/ARNI n(%)

0.91(0.28–2.96)

0.879

\(\beta\)-block n(%)

0.53(0.14–2.04)

0.354

Diuretic n(%)

0.68(0.23–1.99)

0.477

SGLT-2 n(%)

0.56(0.11–2.78)

0.475

Digoxin n(%)

0.71(0.18–2.81)

0.621

EAT volume(cm³)

1.00(0.99–1.02)

0.816

LA-EAT volume (cm³)

0.99(0.96–1.03)

0.546

LVZs n(%)

5.04(1.68–15.13)

0.004

0.26(0.07–0.96)

0.043

Recurrence of AF n(%)

1.11(0.31–3.99)

0.869